APA (7th ed.) Citation

Frankenstein, L., Katus, H., Grundtvig, M., Hole, T., de Blois, J., Schellberg, D., . . . Agewall, S. (2013). Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: A propensity score-matched cohort study. European journal of clinical pharmacology, 69(10), . https://doi.org/10.1007/s00228-013-1512-x

Chicago Style (17th ed.) Citation

Frankenstein, Lutz, Hugo Katus, M. Grundtvig, T. Hole, J. de Blois, Dieter Schellberg, D. Atar, Christian Zugck, and S. Agewall. "Association Between Spironolactone Added to Beta-blockers and ACE Inhibition and Survival in Heart Failure Patients with Reduced Ejection Fraction: A Propensity Score-matched Cohort Study." European Journal of Clinical Pharmacology 69, no. 10 (2013). https://doi.org/10.1007/s00228-013-1512-x.

MLA (9th ed.) Citation

Frankenstein, Lutz, et al. "Association Between Spironolactone Added to Beta-blockers and ACE Inhibition and Survival in Heart Failure Patients with Reduced Ejection Fraction: A Propensity Score-matched Cohort Study." European Journal of Clinical Pharmacology, vol. 69, no. 10, 2013, https://doi.org/10.1007/s00228-013-1512-x.